TY - JOUR T1 - Genetic and morphological estimates of androgen exposure predict social deficits in multiple neurodevelopmental disorder cohorts JF - medRxiv DO - 10.1101/2020.08.03.20155671 SP - 2020.08.03.20155671 AU - Brooke G. McKenna AU - Yongchao Huang AU - Kévin Vervier AU - Dabney Hofamman AU - Mary Cafferata AU - Seima Al-Momani AU - Florencia Lowenthal AU - Angela Zhang AU - Jin-Young Koh AU - Savantha Thenuwara AU - Leo Brueggeman AU - Ethan Bahl AU - Tanner Koomar AU - Natalie Pottschmidt AU - Taylor Kalmus AU - Lucas Casten AU - Taylor R. Thomas AU - Jacob J. Michaelson Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/05/2020.08.03.20155671.abstract N2 - Neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) display a strong male bias. Androgen exposure is one paradigm for investigating this male bias, and previous work has sought to connect morphological proxies of androgen exposure, including digit ratio and facial morphology, to neurodevelopmental outcomes. The results of these studies have been inconsistent and the relationships between androgen exposure and behavior remains unclear. Here, we measured both digit ratio masculinity (DRM) and facial landmark masculinity (FLM) in the same neurodevelopmental cohort (N=763) and compared these proxies of androgen exposure to clinical and parent-reported features. We found that FLM was significantly associated with diagnostic burden in males and females (Z = 3.1, p = 0.002), while DRM was not (Z = −1.6, p = 0.11). When testing for association with parent-reported problems, we found that both FLM and DRM were positively associated with concerns about social behavior (Z = 3.1, p = 0.002; Z = 2.1, p = 0.03, respectively), also in a sex-invariant manner. Furthermore, we found evidence via polygenic risk scores (PRS) that DRM indexes masculinity via testosterone levels (t = 2.0, p = 0.04), while FLM indexes masculinity through a negative relationship with sex hormone binding globulin (SHBG) levels (t = −2.3, p = 0.02). Finally, using the SPARK cohort (N=9,419) we replicated the observed relationship between polygenic estimates of testosterone, SHBG, and social functioning (t = −2.5, p = 0.01, and t = 4.5, p = 6 × 10−6 for testosterone and SHBG, respectively). Remarkably, these quantitative sex effects on social functioning were on the same order of magnitude as the effect of binary sex itself (binary male: −0.23 ± 0.05;testosterone: −0.07 ± 0.026 per SD of PRS; SHBG: 0.11 ± 0.026 per SD of PRS). These findings and their replication in the large SPARK cohort lend strong support to the hypothesis that increasing net androgen exposure diminishes capacity for social functioning in both males and females.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health [MH105527 and447DC014489 to JJM]. This work was supported by a grant from the Simons Foundation (SFARI448516716, JJM). This work was also supported by a grant to the University of Iowa Institution of Clinical and Translational Science, NIH and CTSA grant number: UL1TR002537.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study procedures were approved by the University of Iowa Institutional Review Board, and informed consent was obtained for each participant (IRB 201505743).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenetic and phenotypic data from the devGenes cohort are not publicly available at this time. Data from the SPARK cohort are made available to researchers through https://base.sfari.org. ER -